Apr. 11, 2019


BEAM Alliance and BioCom co-organized the 11th Berlin Conference on Novel Antimicrobials & AMR Diagnostics, which was a great success. The meeting was attended by industry, governments, academics, policy makers and funders all aligned on the acute need to implement financial incentives that work for all, especially SME biotechs, the innovators feeding the antibiotic pipeline.

Highlights involved the announcement of the new Novo REPAIR fund, presentations by CARB-X, GARDP, WHO, UNCTAD and an active discussion on novel criteria to clinically evaluate novel approaches for antimicrobial therapy and prevention, including a video message by Marco Cavaleri, Head of Office, Anti-infectives and Vaccines in the Human Medicines Evaluation Division, EMA.

Berlin Conference